Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients

IMPORTANCE: Biosimilars, or highly similar versions of complex biologic drugs, have the potential to slow drug spending growth; however, biosimilar uptake in the United States has been slow. Little is known about barriers to biosimilar uptake following drug launch. OBJECTIVE: To examine the patient,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Emma Boswell, Johnson, Phyllis, Bond, Amelia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841457/
https://www.ncbi.nlm.nih.gov/pubmed/33502485
http://dx.doi.org/10.1001/jamanetworkopen.2020.34776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841457/
https://www.ncbi.nlm.nih.gov/pubmed/33502485
http://dx.doi.org/10.1001/jamanetworkopen.2020.34776

Ejemplares similares